D'Anne Hurd

Board Member at Eileen Fisher

Speaker

D’Anne Hurd is a qualified financial expert and ESG (environmental and social governance) authority who brings to her board assignments hands-on experience as a senior financial management executive at two Fortune 100 companies. She has served on the boards of four public companies–including as chair and lead independent director–and six private company boards across retail, medical devices, cloud-based SaaS, technology, pharma/biotech, financial services, telecommunications, and manufacturing industries.
Among her public company board positions, Ms. Hurd has served since 2015 as an independent trustee and audit committee member for PAX World Funds/PAX Ellevate Fund (MYTF: PXWEX), a leading sustainable investment mutual fund family integrating ESG measures. For Micronetics, Inc. (NASDAQ: NOIZ), a $100 million designer of microwave test equipment, she served as lead independent director, chair of the nominating and governance committee, and member of the audit and compensation committees (2006-2012). From 1993-2012 for Data Translation, Inc. (OTC: DATX), a USB and Ethernet solutions provider for the test and measurement market, she served as chair of the audit, compensation and nominating/governance committees. And for Vasoactive Pharmaceuticals, Inc. (NASDAQ: VAPH), she served as chair of the audit and governance committees and member of the compensation committee (2004-2010).
Among her private company board positions, most recently, Ms. Hurd joined the board of EILEEN FISHER, Inc. as its first independent director. As chair of the governance committee, she is helping the board instill best practices that reflect the company’s strong values and unique culture. Ms. Hurd has served as chair of the audit and member of the nominating/governance committees since 2013 for Peckham Industries, a fourth-generation family-owned road and bridge construction materials company. From 2011-2014, she served as lead independent director and audit and compensation committee member for Hiperos, LLC, a cloud-based SaaS company providing software-driven supply chain risk management ensuring vendor regulatory compliance for multiple Fortune 500 clients. For Monzite Corporation, a defense and aerospace contract manufacturer, she has served as independent, non-executive chairman of the board (full equity partner) since 2013. And, from 2012-2017, she served on the business advisory board of Myomo, Inc. (NYSE: MYO), an MIT-born medical technology developer of myoelectric self-powered braces that restore limb mobility. (Myomo went public through